메뉴 건너뛰기




Volumn 67, Issue 1, 2015, Pages 11-14

Efficacy of the β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: A post hoc analysis of pooled data from three randomised phase 3 trials

Author keywords

Correlation analysis; Efficacy; Incontinence; Mirabegron; Overactive bladder; Severity

Indexed keywords

MIRABEGRON; PLACEBO; ACETANILIDE DERIVATIVE; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; THIAZOLE DERIVATIVE;

EID: 84925127747     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.06.052     Document Type: Article
Times cited : (44)

References (9)
  • 1
    • 84871925684 scopus 로고    scopus 로고
    • 3-adrenoceptor agonist, in patients with overactive bladder: Results from a randomized European-Australian phase 3 trial
    • 3-adrenoceptor agonist, in patients with overactive bladder: results from a randomized European-Australian phase 3 trial Eur Urol 63 2013 283 295
    • (2013) Eur Urol , vol.63 , pp. 283-295
    • Khullar, V.1    Amarenco, G.2    Angulo, J.C.3
  • 2
    • 84875953225 scopus 로고    scopus 로고
    • Results of a randomized phase III trial of mirabegron in patients with overactive bladder
    • V. Nitti, S. Auerbach, N. Martin, A. Calhoun, M. Lee, and S. Herschorn Results of a randomized phase III trial of mirabegron in patients with overactive bladder J Urol 189 2013 1388 1395
    • (2013) J Urol , vol.189 , pp. 1388-1395
    • Nitti, V.1    Auerbach, S.2    Martin, N.3    Calhoun, A.4    Lee, M.5    Herschorn, S.6
  • 3
    • 84880919880 scopus 로고    scopus 로고
    • A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicenter study to assess the efficacy and safety of the beta-3 agonist mirabegron in patients with symptoms of overactive bladder
    • S. Herschorn, J. Barkin, and D. Castro-Diaz A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicenter study to assess the efficacy and safety of the beta-3 agonist mirabegron in patients with symptoms of overactive bladder Urology 82 2013 313 320
    • (2013) Urology , vol.82 , pp. 313-320
    • Herschorn, S.1    Barkin, J.2    Castro-Diaz, D.3
  • 4
    • 84879121450 scopus 로고    scopus 로고
    • Efficacy of mirabegron in patients with overactive bladder: A pre-specified pooled analysis of 3 randomized, double-blind, placebo-controlled, phase III studies
    • V. Nitti, S. Herschorn, and V. Khullar Efficacy of mirabegron in patients with overactive bladder: a pre-specified pooled analysis of 3 randomized, double-blind, placebo-controlled, phase III studies Int J Clin Pract 67 2013 619 632
    • (2013) Int J Clin Pract , vol.67 , pp. 619-632
    • Nitti, V.1    Herschorn, S.2    Khullar, V.3
  • 5
    • 84884947508 scopus 로고    scopus 로고
    • Comorbidities and personal burden of urgency urinary incontinence: A systematic review
    • K.S. Coyne, A. Wein, S. Nicholson, M. Kvasz, C.I. Chen, and I. Milsom Comorbidities and personal burden of urgency urinary incontinence: a systematic review Int J Clin Pract 67 2013 1015 1033
    • (2013) Int J Clin Pract , vol.67 , pp. 1015-1033
    • Coyne, K.S.1    Wein, A.2    Nicholson, S.3    Kvasz, M.4    Chen, C.I.5    Milsom, I.6
  • 7
    • 14144255564 scopus 로고    scopus 로고
    • The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: Current concepts and future prospects
    • C.R. Chapple, W. Artibani, and L.D. Cardozo The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects BJU Int 35 2005 335 340
    • (2005) BJU Int , vol.35 , pp. 335-340
    • Chapple, C.R.1    Artibani, W.2    Cardozo, L.D.3
  • 8
    • 0032983692 scopus 로고    scopus 로고
    • Functional and molecular biological evidence for a possible β3-adrenoceptor in the human detrusor muscle
    • Y. Igawa, Y. Yamazaki, and H. Takeda Functional and molecular biological evidence for a possible β3-adrenoceptor in the human detrusor muscle Br J Pharmacol 126 1999 819 825
    • (1999) Br J Pharmacol , vol.126 , pp. 819-825
    • Igawa, Y.1    Yamazaki, Y.2    Takeda, H.3
  • 9
    • 0032588710 scopus 로고    scopus 로고
    • Evidence for β3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: Analysis by molecular biological and pharmacological methods
    • M. Takeda, K. Obara, and T. Mizusawa Evidence for β3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods J Pharmacol Exp Ther 288 1999 1367 1373
    • (1999) J Pharmacol Exp Ther , vol.288 , pp. 1367-1373
    • Takeda, M.1    Obara, K.2    Mizusawa, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.